AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nukovax 23 Vaccine

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Pneumococcal Polysaccharide Vaccine (25mcg)

Overview Nukovax 23 Vaccine

Pneumovax 23 protects against pneumococcal illnesses, including pneumonia, meningitis, otitis media, and bacteremia. Administered intramuscularly in the upper arm by a healthcare professional, this vaccine is not self-injectable. A single dose suffices for most individuals, though a booster may be recommended five years post-initial vaccination. Mild side effects like fever and localized injection site reactions (pain, swelling, redness) are possible; persistent or worsening symptoms warrant medical attention. Prior to vaccination, disclose any pre-existing cardiac, hepatic, or renal conditions, and list all current medications. Pregnant or lactating individuals should consult their physician before vaccination.

Uses of Nukovax 23 Vaccine

Safeguarding against pneumonia, meningitis, bloodstream infections, and otitis media.

Major Benefits of Nukovax 23 Vaccine:

A healthcare professional will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

Common Side effects of Nukovax 23 Vaccine:

  • Injection site redness
  • Fever

How to use Nukovax 23 Vaccine:

A healthcare professional will administer medication using this apparatus. Home use instruction may be provided to you or your caregiver.

How Nukovax 23 Vaccine works:

The Nukovax 23 Vaccine triggers immune system development through a harmless, localized response. This process mimics a mild infection without causing disease, prompting the body to generate protective antibodies that prevent subsequent infections.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside the Nukovax 23 Vaccine may present unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the administration of Nukovax 23 Vaccine to pregnant individuals is currently lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Nukovax 23 Vaccine use while breastfeeding is currently unavailable. Seek medical advice from your physician.

DrivingDrivingSAFE

Driving ability is typically unaffected by the Nukovax 23 Vaccine.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Nukovax 23 Vaccine use in individuals with renal impairment is scarce. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Nukovax 23 Vaccine administration to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Nukovax 23 Vaccine :

Omit a Nukovax 23 Vaccine dose? Seek your physician's advice.

Facts to Know About Nukovax 23 Vaccine

LabelValue
Chemical Category Immunizations
Developing Habits No.
Type of Therapy Immunizations

FAQs on Nukovax 23 Vaccine

Nukovax 23 is a non-live virus vaccine. It's made from purified components of 23 pneumococcal bacteria types. While not universally protective, it offers immunity against most pneumococcal infections.
Nukovax 23 employs long-chain polysaccharide molecules, mirroring the bacterial surface capsule. These polysaccharides act as antigens, stimulating antibody production to combat infection.
Nukovax 23 is a safe vaccine, rigorously tested and licensed by health authorities, with ongoing safety monitoring. Minor side effects, such as injection site pain, swelling, or mild fever, may occur but typically resolve within days. Consult a doctor if symptoms persist.
One dose of PPSV is needed for you or your child. A second dose isn't typically given for at least three years and isn't usually necessary for healthy individuals. However, a second dose might be considered 3-5 years after the first for those at higher risk of serious pneumococcal infections (e.g., those without a spleen or with a malfunctioning spleen). Administering a second dose within three years of the first is discouraged due to increased side effect risks.
To optimize Nukovax 23 Vaccine effectiveness, administer it two weeks before splenectomy, chemotherapy, or other immunosuppressive treatments. Avoid vaccination during chemotherapy or radiation. Immune response may be reduced after these therapies; therefore, vaccinate at least three months post-treatment. Consider a longer delay after extensive or prolonged treatment.
Nukovax 23 and other vaccines, including influenza, may be administered concurrently, but using separate syringes and injection sites. Simultaneous vaccination is generally effective in preventing both infections.
Vaccination is generally safe for minor illnesses like colds. However, postpone vaccination if you have a fever or serious ongoing health condition; consult your doctor before proceeding.
Nukovax 23 Vaccine
1,810
MRP 2,100
13% off